Combinatorial therapy for triple negative breast cancer using hyperstar polymer-based nanoparticles†
Abstract
We report the ability of a novel combinatorial therapy obtained from nanoparticles of hyperstar polymers encompassing drugs to selectively target triple negative breast cancer (TNBC) cell proliferation through STAT3 and topoisomerase-II pathways. This nano-cocktail was at least two to four fold better than the individual drugs and 6–20 times more selective than the parent drugs.
 
                



 Please wait while we load your content...
                                            Please wait while we load your content...
                                        